APRE
Aprea Therapeutics Inc
$0.75
0.02 (2.34%) Today
0.02 (2.53%) After-hours
— up— down
Market Cap
$9M-49.0%
Revenue (TTM)
$1.24K-99.4%
Net Income (TTM)
$-13,324,594
$-13,324,594EPS (TTM)
-1.08
-1.08Shares Out
12.38M
12.38MOpen
$0.80
$0.80Previous Close
$0.75
$0.75Day Range
$0.75 – $0.82
$0.75 – $0.8252-Week Range
$0.55 – $1.69
$0.55 – $1.69Beta
-1.20
-1.20Earnings Date
Nov 10, 2026
Nov 10, 2026Volume
584.51K
584.51KAvg Volume
202.70K
202.70KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout APRE
Related
News
N/AN/A
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
Yahoo · 1w ago
Aprea Therapeutics Announces Abstract Featuring Updated Interim Results From The Ongoing Phase 1 ACESOT-1051 Study Of Its WEE1 Inhibitor APR-1051 In Patients With Advanced Solid Tumors Has Been Accepted For Oral Presentation At The Symposium On Molecular Targets And Cancer Therapeutics
Benzinga · 1w ago